- Primary malignant melanoma of the uterine cervix treated with pembrolizumab after radical surgery: a case report and literature review
-
Kim MS, Choi CH, Kim TJ, Lee JW, Lee J, Bae DS, Kim BG
- KMID: 2439727
- Obstet Gynecol Sci.
- 2018 Jul;61(4):524-528.
- doi: 10.5468/ogs.2018.61.4.524
Malignant melanoma of the genital tract is a rare disease that is usually diagnosed by chance. When a definite diagnosis is delayed, the prognosis is very poor without standardized treatment.... -
- CITED
-
- Close
- SHARE
-
- Close
- Angiographically Documented Macular Ischemia after Single Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion
-
Lee KH, Kang EC, Koh HJ
- KMID: 2419132
- Yonsei Med J.
- 2017 May;58(3):676-678.
- doi: 10.3349/ymj.2017.58.3.676
This report describes a case of angiographically documented foveal avascular zone (FAZ) enlargement after a single intravitreal injection of bevacizumab for macular edema secondary to central retinal vein occlusion (CRVO).... -
- CITED
-
- Close
- SHARE
-
- Close
- Update on immune checkpoint inhibitors in gynecological cancers
-
Heong V, Ngoi N, Tan DS
- KMID: 2413459
- J Gynecol Oncol.
- 2017 Mar;28(2):e20.
- doi: 10.3802/jgo.2017.28.e20
In recent years, progress in our understanding of immune-modulatory signaling pathways in immune cells and the tumor microenvironment (TME) has led to rejuvenated interest in cancer immunotherapy. In particular, immunotherapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea
-
Cheong HI, Jo SK, Yoon SS, Cho H, Kim JS, Kim YO, Koo JR, Park Y, Park YS, Shin JI, Yoo KH, Oh D
- KMID: 2468240
- J Korean Med Sci.
- 2016 Oct;31(10):1516-1528.
- doi: 10.3346/jkms.2016.31.10.1516
Atypical hemolytic uremic syndrome (aHUS) is a rare syndrome characterized by micro-angiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. The major pathogenesis of aHUS involves dysregulation of the complement system.... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors Contributing to the Preference of Korean Patients with Crohn's Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)
-
Kim ES, Kim KO, Jang BI, Lee CK, Kim HJ, Lee KM, Kim YS, Eun CS, Jung SA, Yang SK, Lee J, Kim TO, Jung Y, Seo GS, Yoon SM, the IBD Study Group of the Korean Association for the Study of the Intestinal Diseases (KASID)
- KMID: 2411966
- Gut Liver.
- 2016 May;10(3):391-398.
- doi: 10.5009/gnl15126
BACKGROUND/AIMS: Two comparable anti-tumor necrosis factor (TNF) agents with different routes of administration (intravenous [iv] infliximab [IFX] vs subcutaneous [sc] adalimumab [ADA]) are available for patients with Crohn's disease (CD)... -
- CITED
-
- Close
- SHARE
-
- Close
- Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis
-
Kim JH, Cheon JH
- KMID: 2363960
- Gut Liver.
- 2016 Mar;10(2):162-163.
- doi: 10.5009/gnl16024
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Golimumab Therapy in Ulcerative Colitis
-
Moon W
- KMID: 2383543
- Korean J Gastroenterol.
- 2016 Feb;67(2):64-73.
- doi: 10.4166/kjg.2016.67.2.64
Ulcerative colitis is a chronic inflammatory condition of the colon, characterized by diffuse mucosal inflammation and blood-mixed diarrhea. The main treatment has been 5-aminosalicylic acid, steroid, thiopurine, and anti-tumor necrosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry
-
Jang JH, Kim JS, Yoon SS, Lee JH, Kim YK, Jo DY, Chung J, Sohn SK, Lee JW
- KMID: 2360045
- J Korean Med Sci.
- 2016 Feb;31(2):214-221.
- doi: 10.3346/jkms.2016.31.2.214
Paroxysmal nocturnal hemoglobinuria (PNH) is a progressive, systemic, life-threatening disease, characterized by chronic uncontrolled complement activation. A retrospective analysis of 301 Korean PNH patients who had not received eculizumab was... -
- CITED
-
- Close
- SHARE
-
- Close
- Emerging Therapies for Osteoporosis
-
McClung MR
- KMID: 2169649
- Endocrinol Metab.
- 2015 Dec;30(4):429-435.
- doi: 10.3803/EnM.2015.30.4.429
Although several effective therapies are available for the treatment of osteoporosis in postmenopausal women and older men, there remains a need for the development of even more effective and acceptable... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of Patient Pain Experience during Intravitreal 27-Gauge Bevacizumab and 30-Gauge Ranibizumab Injection
-
Guler M, Bilgin B, Capkin M, Simsek A, Bilak S
- KMID: 2363758
- Korean J Ophthalmol.
- 2015 Jun;29(3):190-194.
- doi: 10.3341/kjo.2015.29.3.190
PURPOSE: To compare pain scores of patients during intravitreal 27-gauge bevacizumab and 30-gauge ranibizumab injection procedures. METHODS: Seventy eyes of 70 patients who had not previously undergone intravitreal anti-vascular endothelial growth... -
- CITED
-
- Close
- SHARE
-
- Close
- Current and Emerging Biologics for Ulcerative Colitis
-
Park SC, Jeen YT
- KMID: 2380778
- Gut Liver.
- 2015 Jan;9(1):18-27.
- doi: 10.5009/gnl14226
Conventional medical treatment for ulcerative colitis can have limited efficacy or severe adverse reactions requiring additional treatment or colectomy. Hence, different biological agents that target specific immunological pathways are being... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug Survival Rates of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
-
Kang JH, Park DJ, Lee JW, Lee KE, Wen L, Kim TJ, Park YW, Lee SS
- KMID: 1794597
- J Korean Med Sci.
- 2014 Sep;29(9):1205-1211.
- doi: 10.3346/jkms.2014.29.9.1205
We investigated the compliance of Korean patients using tumor necrosis factor (TNF) inhibitors to treat rheumatoid arthritis (RA) and ankylosing spondylitis (AS), and identified potential predictors associated with treatment discontinuation.... -
- CITED
-
- Close
- SHARE
-
- Close
- Trastuzumab-Conjugated Liposome-Coated Fluorescent Magnetic Nanoparticles to Target Breast Cancer
-
Jang M, Yoon YI, Kwon YS, Yoon TJ, Lee HJ, Hwang SI, Yun BL, Kim SM
- KMID: 1731043
- Korean J Radiol.
- 2014 Aug;15(4):411-422.
- doi: 10.3348/kjr.2014.15.4.411
OBJECTIVE: To synthesize mesoporous silica-core-shell magnetic nanoparticles (MNPs) encapsulated by liposomes (Lipo [MNP@m-SiO2]) in order to enhance their stability, allow them to be used in any buffer solution, and to... -
- CITED
-
- Close
- SHARE
-
- Close
- Ranibizumab Injection for Corneal Neovascularization Refractory to Bevacizumab Treatment
-
Ahn YJ, Hwang HB, Chung SK
- KMID: 1792113
- Korean J Ophthalmol.
- 2014 Apr;28(2):177-180.
- doi: 10.3341/kjo.2014.28.2.177
Vascular endothelial growth factor inhibitor is an emerging therapeutic modality for various ocular diseases with neovascularization (NV). However, for corneal NV, controversy remains regarding whether bevacizumab or ranibizumab is superior.... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum Concentration of Vascular Endothelial Growth Factor after Bilateral Intravitreal Injection of Bevacizumab
-
Wang D, Choi KS, Lee SJ
- KMID: 1792092
- Korean J Ophthalmol.
- 2014 Feb;28(1):32-38.
- doi: 10.3341/kjo.2014.28.1.32
PURPOSE: This study compared serum vascular endothelial growth factor (VEGF) concentration between patients given the bilateral and unilateral intravitreal injections of bevacizumab. METHODS: In a prospective manner, serum VEGF levels in... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Injection of Intravitreal Drugs with Standard Care in Macular Edema Secondary to Branch Retinal Vein Occlusion
-
Lee K, Jung H, Sohn J
- KMID: 1792090
- Korean J Ophthalmol.
- 2014 Feb;28(1):19-25.
- doi: 10.3341/kjo.2014.28.1.19
PURPOSE: To compare the long-term efficacy and safety of intravitreal triamcinolon with or without rescue laser therapy (intravitreal triamcinolone injection [IVTA] group), bevacizumab with or without rescue laser treatment (intravitreal... -
- CITED
-
- Close
- SHARE
-
- Close
- Safe Re-administration of Tumor Necrosis Factor-alpha (TNFalpha) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFalpha Therapy
-
Suh YS, Kwok SK, Ju JH, Park KS, Park SH, Yoon CH
- KMID: 1796912
- J Korean Med Sci.
- 2014 Jan;29(1):38-42.
- doi: 10.3346/jkms.2014.29.1.38
There is no consensus on whether it is safe to re-administer tumor necrosis factor-alpha (TNFalpha) inhibitors in patients with rheumatoid arthritis (RA) or ankylosing spondylitis (AS) flared after withdrawal of... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-VEGF-refractory Exudative Age-related Macular Degeneration: Differential Response According to Features on Optical Coherence Tomography
-
Shin JY, Woo SJ, Ahn J, Park KH
- KMID: 1792078
- Korean J Ophthalmol.
- 2013 Dec;27(6):425-432.
- doi: 10.3341/kjo.2013.27.6.425
PURPOSE: To describe optical coherence tomography (OCT) characteristics of neovascular age-related macular degeneration (AMD) patients refractory to intravitreal anti-vascular endothelial growth factor (VEGF) injections (ranibizumab, bevacizumab) and their responses to... -
- CITED
-
- Close
- SHARE
-
- Close
- Body Weight and Bone Density Changes in Patients with Ankylosing Spondylitis Receiving Anti-Tumor Necrosis Factor-alpha Treatment
-
Lee J, Jung M, Kim D, Lee S, Oh SK, Jo Y, Byun S, Nam K, Lee C
- KMID: 2267771
- Korean J Med.
- 2013 Nov;85(5):489-494.
BACKGROUND/AIMS: To determine the changes in body weight and bone mineral density in patients with ankylosing spondylitis (AS) receiving anti-tumor necrosis factor-alpha (TNF-alpha) treatment. METHODS: Thirty-one patients with AS (25 males... -
- CITED
-
- Close
- SHARE
-
- Close
- Cetuximab Related Eyelash Elongations for Patients with Metastatic Rectum Carcinoma: Metabolic Complete Response
-
Urun Y, Utkan G
- KMID: 2265075
- Ann Dermatol.
- 2013 Nov;25(4):504-505.
- doi: 10.5021/ad.2013.25.4.504
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
